{"name": "Noxxon Pharma",
 "permalink": "noxxon-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/noxxon-pharma",
 "homepage_url": "http://www.noxxon.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+ 49 30 726247-0",
 "description": "",
 "created_at": "Fri May 28 03:39:49 UTC 2010",
 "updated_at": "Thu Oct 21 05:23:37 UTC 2010",
 "overview": "\u003Cp\u003ENOXXON Pharma AG, a biopharmaceutical company, develops biostable aptamers and substances based on mirror image nucleic acids. Its Spiegelmer is a mirror image oligonucleotide therapeutic for the pharmacologically relevant target. The company has a strategic alliance with Pfizer, Inc. NOXXON Pharma AG was founded in 1997 and is based in Berlin, Germany.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       27],
      "assets/images/resized/0008/8846/88846v1-max-150x150.png"],
     [[250,
       46],
      "assets/images/resized/0008/8846/88846v1-max-250x250.png"],
     [[330,
       61],
      "assets/images/resized/0008/8846/88846v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Frank",
      "last_name": "Morich",
      "permalink": "frank-morich",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "Sven",
      "last_name": "Klussmann",
      "permalink": "sven-klussmann",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u20ac35M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.fiercebiotech.com/story/noxxon-adds-venture-backers-33m-round/2010-05-27?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Noxxon adds to venture backers with \u00e2\u201a\u00ac33M round",
    "raised_amount": 33000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 5,
    "funded_day": 27,
    "investments":
     []},
   {"round_code": "d",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020101012e6ad0012x\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Noxxon Pharma Adds $2.8M To Series D  ",
    "raised_amount": 2000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2010,
    "funded_month": 10,
    "funded_day": 13,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Max-Dohrn-Strasse 8-10",
    "address2": "",
    "zip_code": "10589 ",
    "city": "Berlin",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}